Bay Colony Advisory Group Inc d b a Bay Colony Advisors Has $343,000 Stock Holdings in Danaher Corporation (NYSE:DHR)

Bay Colony Advisory Group Inc d b a Bay Colony Advisors reduced its stake in Danaher Corporation (NYSE:DHR) by 42.9% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,666 shares of the conglomerate’s stock after selling 1,253 shares during the period. Bay Colony Advisory Group Inc d b a Bay Colony Advisors’ holdings in Danaher were worth $343,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. LaFleur & Godfrey LLC raised its holdings in Danaher by 1.5% in the fourth quarter. LaFleur & Godfrey LLC now owns 29,855 shares of the conglomerate’s stock worth $6,853,000 after purchasing an additional 440 shares during the period. Union Bancaire Privee UBP SA bought a new stake in shares of Danaher in the 4th quarter valued at $74,551,000. Bank Pictet & Cie Europe AG grew its stake in Danaher by 22.8% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate’s stock valued at $44,241,000 after acquiring an additional 35,730 shares during the period. Strategic Financial Concepts LLC bought a new stake in shares of Danaher in the fourth quarter worth about $31,000. Finally, D.A. Davidson & CO. raised its position in shares of Danaher by 11.6% during the fourth quarter. D.A. Davidson & CO. now owns 14,835 shares of the conglomerate’s stock worth $3,405,000 after purchasing an additional 1,541 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Insider Transactions at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now directly owns 3,105,808 shares of the company’s stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

DHR has been the topic of several research analyst reports. Stifel Nicolaus upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a report on Friday, March 14th. Argus lowered their price objective on shares of Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Citigroup reiterated a “buy” rating on shares of Danaher in a report on Monday, April 7th. Finally, TD Cowen lifted their price target on Danaher from $240.00 to $248.00 and gave the company a “buy” rating in a research note on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $248.17.

Danaher Trading Up 0.9%

Shares of Danaher stock opened at $196.23 on Friday. The stock has a market cap of $140.43 billion, a P/E ratio of 38.10, a P/E/G ratio of 2.73 and a beta of 0.77. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $281.70. The business’s 50 day moving average is $193.89 and its 200-day moving average is $209.69.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. Equities research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher’s dividend payout ratio is 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.